R-h Xu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies.

Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies.

Journal: ESMO open

Published: December 17, 2025

Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer.

Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer.

Journal: ESMO open

Published: April 03, 2025

Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials.

Inhibitor of apoptosis proteins (IAP) inhibitor APG-1387 monotherapy or in combination with programmed cell death 1 (PD-1) inhibitor toripalimab in patients with advanced solid tumors: results from two phase I trials.

Journal: ESMO open

Published: April 10, 2024

Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials.

Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials.

Journal: ESMO open

Published: March 19, 2024

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.

Journal: ESMO open

Published: March 20, 2023

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 21, 2017

Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.

Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.

Journal: Oncogene

Published: February 09, 2017

Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.

Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.

Journal: The British journal of surgery

Published: October 04, 2016

ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition.

ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition.

Journal: Leukemia

Published: July 19, 2016

Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.

Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.

Journal: Oncogene

Published: October 29, 2015

Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.

Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.

Journal: British journal of cancer

Published: March 08, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026